ResMed, Inc. (RMD)
245.78
-13.84
(-5.33%)
USD |
NYSE |
Feb 12, 16:00
245.00
-0.78
(-0.32%)
After-Hours: 18:39
ResMed Cash from Investing (Quarterly) : -50.94M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Abbott Laboratories | -- |
| Baxter International, Inc. | -111.00M |
| Stryker Corp. | -305.00M |
| Insulet Corp. | -31.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 339.74M |
| Cash from Financing (Quarterly) | -258.35M |
| Free Cash Flow | 1.777B |
| Free Cash Flow Per Share (Quarterly) | 2.085 |
| Free Cash Flow to Equity (Quarterly) | 303.82M |
| Free Cash Flow to Firm (Quarterly) | 305.19M |
| Free Cash Flow Yield | 4.92% |